Please sign in with your existing account details.
Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.
Privacy statement - Terms and conditions
Forgotten your password?
You have exceeded the maximum number of login attempts for this email address and your account has been locked. An email has been sent to member of Browne Jacobson's web team and some one will be contacting you over the next two working days with details of how to change your password.
Are you sure you want to remove this item from you pinned content?
The campaign hitting the headlines over the last few months is over; the DfE have stepped in and replaced Downhills Primary School’s governing body with a high-profile interim-executive board (IEB). This follows several years of underperformance and an Ofsted inspection that resulted in the school being placed in special measures.
The IEB includes the chair of the Young People’s Learning Agency, Les Walton, head of the Harris Federation, Dr Dan Moyniham, and Dame Sylvia Morris who are now consulting on whether or not the school should convert to academy status.
The power to replace a governing body has only been used three times since its introduction under s.69 of the Education and Inspections Act 2006. However, with the government determined to raise educational standards quickly and tackle failing schools this may be the first of a number of ‘take-overs’. The message is clear: if you are a governor of a failing school and resist calls to become an academy your days could be numbered.
With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.
View blog
The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.
Our top tips for supporting transgender and non-binary pupils.
On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.
Senior Associate
Select which mailings you would like to receive from us.
Sign up